Emily K. Dalton
Emily K. Dalton spoke at National Society of Genetic Counselors (NSGC) Annual Conference 2026 in November 2026 (moderator, “Demystifying MRD: The Genetic Counselor’s Role in ctDNA-Based Cancer Monitoring and Minimal Residual Disease Detection”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Emily. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Emily Dalton is an Associate Director of Oncology Medical Affairs at Illumina. In her 4 years at Illumina, she has managed evidence generation projects centered on generating data to support the clinical utility of comprehensive genomic profiling and whole genome sequencing in oncology and provided education on those topics to diverse stakeholders. Prior to Illumina, she worked at Ambry Genetics for 9 years, ultimately serving as the Director of the Genomic Science Liaison team. She is a genetic counselor by training and started her career practicing clinically as an oncology genetic counselor at the Dana-Farber Cancer Institute in Boston.